✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Pharmaids Pharmaceuticals Ltd.

PHARMAID

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹179 Cr.
P/E
0.00

Pharmaids Pharmaceuticals Ltd.

  • Pharmaids Pharma
  • IndoAmerican Advance
  • Coral Laboratories

FAQs on Pharmaids Pharmaceuticals Ltd. Shareprice

Pharmaids Pharma has given better returns compared to its competitors.
Pharmaids Pharma has grown at ~35.0% over the last 9yrs while peers have grown at a median rate of 9.0%

Pharmaids Pharma is not expensive.
Latest PE of Pharmaids Pharma is 0.0, while 3 year average PE is 44.5.
Also latest EV/EBITDA of Pharmaids Pharma is 0.0 while 3yr average is 67.56.

View FAQ's On Business

Growth Table

  • Pharmaids Pharmaceuticals Ltd.
  • IndoAmerican Advance
  • Coral Laboratories

Balance Sheet

  • Pharmaids Pharmaceuticals Ltd.
  • IndoAmerican Advance
  • Coral Laboratories

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Pharmaids Pharmaceuticals Ltd.
  • IndoAmerican Advance
  • Coral Laboratories

Cash Flow

  • Pharmaids Pharmaceuticals Ltd.
  • IndoAmerican Advance
  • Coral Laboratories

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Pharmaids Pharmaceuticals Ltd.
  • IndoAmerican Advance
  • Coral Laboratories

Quarterly Results

  • Pharmaids Pharmaceuticals Ltd.
  • IndoAmerican Advance
  • Coral Laboratories

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Pharmaids Pharmaceuticals Ltd. Financials

Balance sheet of Pharmaids Pharma is moderately strong, But short term working capital might become an issue for this company.

Yes, The net debt of Pharmaids Pharma is increasing.
Latest net debt of Pharmaids Pharma is ₹30.96 Crs as of Mar-25.
This is greater than Mar-24 when it was -₹4.23 Crs.

No, profit is decreasing.
The profit of Pharmaids Pharma is -₹15.7 Crs for TTM, -₹10.78 Crs for Mar 2025 and -₹7.97 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Pharmaids Pharma latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Inventory

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech